Company Filing History:
1 out of 6 
1 out of 1 
1 out of 1 Years Active: 2011-2014
Title: The Innovative Mind of Gilles Pain
Introduction
Gilles Pain is a notable inventor based in Castelforte, Italy, who has made significant contributions to the field of therapeutic agents with a focus on mitochondrial health. With a total of four patents to his name, he stands out for his innovative approach to addressing medical challenges associated with mitochondrial permeability transition.
Latest Patents
Gilles Pain's most recent patents revolve around Acrylamido derivatives, which serve as inhibitors of the mitochondrial permeability transition pore (MPTP). These compounds are particularly promising for the prevention and treatment of diseases linked to ischemia/reperfusion and oxidative or degenerative tissue damage. The patents detail the structural formula of these compounds, specifically where R, R', R'', W, and a are defined in the specification. Additionally, the inventions encompass the preparation of these compounds and their incorporation into pharmaceutical compositions, highlighting their potential in the medical field.
Career Highlights
Throughout his career, Gilles Pain has been associated with reputable companies, including Dac S.r.l. and Congenia Srl. In these roles, he has demonstrated a commitment to advancing research in innovative therapeutic solutions, leveraging his expertise in chemical compounds and their applications in medicine.
Collaborations
Gilles Pain has collaborated with talented individuals such as Saverio Minucci and Marco Ballarini, who have contributed to the development of his groundbreaking work. These collaborations have not only enriched his inventions but also fostered a culture of innovation that encourages continued research and advancements in their shared field of interest.
Conclusion
Gilles Pain exemplifies the spirit of innovation in the realm of medical science. With his noteworthy patents and collaborations, he continues to strive towards enhancing therapeutic strategies that could significantly improve patient outcomes in various diseases related to mitochondrial dysfunction. His work underscores the critical role of inventors in shaping the future of healthcare through inventive approaches.